More than six in ten Americans had some sort of symptom signaling poor digestive health in just the past week, yet most still have no way to track what’s happening

It’s the latest industry recommendation: that health plans move routine Utilization Management (UM) in-house and leave complex, specialty care to the experts. As both a nurse and a clinical operations

Argenx established itself in immunology with a single drug offering potential use across a range of rare inflammatory disorders. The biotech is now expanding to more prevalent conditions through a

Value-based care has become one of the most misunderstood terms in the healthcare industry, according to Lakshmi Halasyamani, chief clinical officer at Endeavor Health. She said hospitals tend to treat

Prior authorization has become one of healthcare’s most expensive administrative bottlenecks, affecting far more than physician practices. Across hospitals and health systems, it slows patient access, adds labor-intensive work, increases

Healh insurers are interested in assessing the potential for AI to improve everything from prior authorization to member management. But data fragmentation poses an enormous challenge to AI readiness in

Crystalys Therapeutics does not yet have data from pivotal tests of its gout drug, but the company is already looking ahead to potentially bringing the drug to the market, plans

Candid Health, a revenue cycle management platform, announced Wednesday that it raised $120 million in Series D funding. San Francisco-based Candid Health serves medical groups, managed service organizations and digital

Healthcare has weathered tech-driven capital waves before, like the dot-com boom or the dawn of DNA sequencing — but this one is different, according to a panel of four investors.

Healthcare venture investing has always been a competition to identify the best companies. This next decade will belong to the investors identifying the best breakthroughs before they become companies at